Incidence of Herpes Simplex Virus Type 2 Infection Among African Women Using Depot Medroxyprogesterone Acetate, a Copper Intrauterine Device, or a Levonorgestrel Implant for Contraception: A Nested Randomized Trial.

Mugo NR, Stalter RM, Heffron R, Rees H, Scoville CW, Morrison C, Kourtis AP, Bukusi E, Beksinka M, Philip NM, Beesham I, Deese J, Edward V, Donnell D, Baeten JM, Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium

Open source

DOI
10.1093/cid/ciab1027
Published
2022 Sep 10
Container
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/cid/ciab1027,
  title = {Incidence of Herpes Simplex Virus Type 2 Infection Among African Women Using Depot Medroxyprogesterone Acetate, a Copper Intrauterine Device, or a Levonorgestrel Implant for Contraception: A Nested Randomized Trial.},
  author = {Mugo NR and Stalter RM and Heffron R and Rees H and Scoville CW and Morrison C and Kourtis AP and Bukusi E and Beksinka M and Philip NM and Beesham I and Deese J and Edward V and Donnell D and Baeten JM and Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium},
  year = {2022},
  journal = {Clinical infectious diseases : an official publication of the Infectious Diseases Society of America},
  doi = {10.1093/cid/ciab1027},
  url = {https://doi.org/10.1093/cid/ciab1027}
}

RIS

TY  - JOUR
TI  - Incidence of Herpes Simplex Virus Type 2 Infection Among African Women Using Depot Medroxyprogesterone Acetate, a Copper Intrauterine Device, or a Levonorgestrel Implant for Contraception: A Nested Randomized Trial.
AU  - Mugo NR
AU  - Stalter RM
AU  - Heffron R
AU  - Rees H
AU  - Scoville CW
AU  - Morrison C
AU  - Kourtis AP
AU  - Bukusi E
AU  - Beksinka M
AU  - Philip NM
AU  - Beesham I
AU  - Deese J
AU  - Edward V
AU  - Donnell D
AU  - Baeten JM
AU  - Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium
PY  - 2022
JO  - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
DO  - 10.1093/cid/ciab1027
UR  - https://doi.org/10.1093/cid/ciab1027
ER  - 

APA

NR, M., RM, S., R, H., H, R., CW, S., C, M., AP, K., E, B., M, B., NM, P., I, B., J, D., V, E., D, D., JM, B., & Consortium, E. F. C. O. A. H. O. (. T. (2022). Incidence of Herpes Simplex Virus Type 2 Infection Among African Women Using Depot Medroxyprogesterone Acetate, a Copper Intrauterine Device, or a Levonorgestrel Implant for Contraception: A Nested Randomized Trial.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. https://doi.org/10.1093/cid/ciab1027

Source records